Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 3
1998 1
2001 1
2003 1
2004 1
2005 2
2008 2
2010 1
2019 1
2020 2
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data.
Kareva I, Zutshi A, Mateo CV, Papasouliotis O. Kareva I, et al. Among authors: papasouliotis o. Eur J Drug Metab Pharmacokinet. 2021 Sep;46(5):601-611. doi: 10.1007/s13318-021-00706-z. Epub 2021 Jul 30. Eur J Drug Metab Pharmacokinet. 2021. PMID: 34328632 Free PMC article. Review.
Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data.
Kareva I, Zutshi A, Mateo CV, Papasouliotis O. Kareva I, et al. Among authors: papasouliotis o. Eur J Drug Metab Pharmacokinet. 2021 Nov;46(6):827. doi: 10.1007/s13318-021-00719-8. Eur J Drug Metab Pharmacokinet. 2021. PMID: 34581976 Free PMC article. No abstract available.
Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations.
Xiong W, Hietala SF, Nyberg J, Papasouliotis O, Johne A, Berghoff K, Goteti K, Dong J, Girard P, Venkatakrishnan K, Strotmann R. Xiong W, et al. Among authors: papasouliotis o. Cancer Chemother Pharmacol. 2022 Jul;90(1):53-69. doi: 10.1007/s00280-022-04441-3. Epub 2022 Jun 30. Cancer Chemother Pharmacol. 2022. PMID: 35771259 Free PMC article. Clinical Trial.
19 results